Forget FXI. The South Korea Fund Beating China's AI Trade Charges 19% Less
The iShares China Large-Cap ETF (NYSEARCA:FXI) is the default way most U.S.
FXI And MCHI: China Is A Perfect Example Of A Value Trap
I reiterate my sell rating on Chinese equity ETFs FXI and MCHI, citing persistent macroeconomic and structural headwinds. Despite attractive 9x P/E valuations, Chinese stocks remain value traps due to falling profit margins, rising corporate leverage, and ongoing deflationary pressures. China's shift from real estate-driven growth to high-value exports is fraught with risk, as excess supply and weak domestic demand undermine recovery.
Banco Bilbao Vizcaya Argentaria S.A. Sells 165,037 Shares of iShares China Large-Cap ETF $FXI
Banco Bilbao Vizcaya Argentaria S.A. reduced its holdings in iShares China Large-Cap ETF (NYSEARCA:FXI) by 32.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 343,700 shares of the exchange traded fund's stock after selling 165,037 shares during the period. Banco
China consumer inflation hits three-year high as producer deflation eases
China's consumer inflation recorded the biggest jump in more than three years. Consumer price index rose 1.3% in February from a year earlier, beating economists' forecast for a 0.8% increase in a Reuters poll.
Chinese Stocks And The FXI After The Supreme Court Ruling On U.S. Tariffs
I reiterate a Buy rating on the iShares China Large-Cap ETF, citing compelling valuation and bullish technical momentum. FXI trades at a blended P/E of 13.27 versus SPY's 24.43 and yields 2.37%, reflecting both value and geopolitical risk. The recent Supreme Court tariff ruling triggered a bullish key reversal in FXI, highlighting resilience amid U.S.-China trade policy uncertainty.
What Lies Ahead for China ETFs in the New Year of the Horse?
China ETFs enter the Year of the Horse with cheap valuations, AI momentum and policy support, but property woes, weak consumption and geopolitics may keep volatility elevated.
FXI: Stocks Replace Real Estate
I upgraded iShares China Large-Cap ETF to Buy, citing robust local capital flows and policy support. FXI offers over 22% consensus upside and a 2% dividend yield, with key holdings out-yielding local deposits and bonds. Portfolio EPS growth is projected at 11% for 2026 and 15% for 2027, with a YE26 PE of 13x, yielding an attractive PEG of 1x.
China manufacturing activity expands for the first time since March, beating expectations
China's economy ended the year on a slightly less gloomy note as manufacturing, services and construction activity all improved in December.
FXI And MCHI: See Why China May Have Already Lost The AI Race
I reiterate a sell rating on assets that track the main Chinese indices, citing an unattractive risk-return profile and persistent macro headwinds. China is prioritizing technological leadership in AI over real economic growth, risking further economic slowdown and instability. FXI trades at 12x earnings, in line with its 5-year average, offering no compelling valuation discount despite heightened risks.
Can China's Markets Shed 'Uninvestable' Tag for Good?
Once labeled “uninvestable,” China's markets have rebounded this year. Stocks, onshore bonds, and the yuan are trending higher, signaling renewed investor confidence.
Update On The Chinese Large-Cap FXI ETF: Risky But Undervalued
iShares China Large-Cap ETF offers significant upside potential as Chinese stocks remain undervalued compared to global peers. FXI has shown a strong bullish trend since early 2024, with technical resistance at $42 and upside targets at $54.52 and $73.19. FXI boasts high liquidity and momentum grades, but investors should be mindful of U.S.-China tensions and FXI's expense ratio.
China's Equity Rebound Looks Sustainable, FXI Offers Value (Rating Upgrade)
China Large Cap ETF is upgraded to a "Buy," reflecting strong momentum and attractive valuation after a 78% rally since late 2023. FXI offers exposure to 50 large-cap Chinese stocks, with high liquidity and a 2.44% dividend yield, but carries notable volatility risk. Current valuation remains compelling at under 12x earnings, with a PEG ratio supported by a 6.4% long-term EPS growth rate.
